期刊文献+

CD105在肿瘤抗血管治疗中的研究与进展 被引量:2

暂未订购
导出
摘要 新生血管为肿瘤生长、扩散和转移提供营养来源,是肿瘤生长和转移的推动力,并为肿瘤组织的增殖提供了基础。CD105是新生血管内皮细胞增殖的标志物之一,标记具有增殖活性的内皮细胞,主要表达在肿瘤的新生血管。与以往泛血管内皮标记因子相比,CD105是一种敏感性较强的新生血管生成标志物,能更准确反映肿瘤的扩散速度和转移情况,可作为衡量血管内皮细胞增殖状态的指标之一。因此,以CD105为靶向抑制肿瘤新生血管生长的治疗肿瘤的新方法成为了目前研究的热点。
出处 《中国肿瘤外科杂志》 CAS 2012年第2期111-114,共4页 Chinese Journal of Surgical Oncology
  • 相关文献

参考文献19

  • 1Nyberg P,Salo T,Kalluri R. Tumor microenvironment and angiogenesis[J].Frontiers in Bioscience,2008.6537-6553.
  • 2Quackenbush EJ,Letarte M. Identification of several cell surface proteins of non-T,non-B acute lymphoblastic leukemia by using monoclonal antibodies[J].Journal of Immunology,1985,(02):1276-1285.
  • 3Gougos A,Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line[J].Journal of Immunology,1988,(06):1925-1933.
  • 4Gougos A,Letarte M. Biochemical characterization of the 44G4 antigen from the HOON pre-B leukemic cell line[J].Journal of Immunology,1988,(06):1934-1940.
  • 5Seon BK,Haba A,Matsuno F. Endoglin-targeted cancer therapy[J].Current Drug Delivery,2011,(01):135-143.
  • 6Pérez-Gómez E,Del Castillo G,Juan Francisco S. The role of the TGF-β coreceptor endoglin in cancer[J].Scientific World Journal,2010.2367-2384.
  • 7Ríus C,Smith JD,Almendro N. Cloning of the promoter region of human endoglin,the target gene for hereditary hemorrhagic telangiectasia type 1[J].Blood,1998,(12):4677-4690.
  • 8Medetoglu B,Gunluoglu MZ,Demir A. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer[J].Journal of Thoracic and Cardiovascular Surgery,2010,(05):996-1000.
  • 9Mineo TC,Ambrogi V,Baldi A. Prognostic impact of VEGF,CD31,CD34,and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer[J].Journal of Clinical Pathology,2004,(06):591-597.
  • 10蒋雪峰;卞修武;王清良.CD105在胶质瘤中不同血管的表达及病理分级的关系[A],2009.

二级参考文献49

  • 1黄海燕,朱勇,庄然,许晓光,刘雪松,宋朝君,曹云新,金伯泉.应用红细胞花环形成试验筛选肿瘤膜抗原单克隆抗体[J].第四军医大学学报,2004,25(14):1343-1344. 被引量:33
  • 2梁青春,魏启幼,李美蓉,张利群.CD34与MMP-2在大肠癌中的表达及其与血管生成的关系[J].中国现代医学杂志,2005,15(2):214-217. 被引量:2
  • 3徐青,张一心,王志伟,陈玉泉.肝癌组织微血管计数的临床意义[J].肝胆胰外科杂志,2005,17(1):11-13. 被引量:10
  • 4肖颖丽,梁志清,邱敏.卵巢上皮性肿瘤中缺氧诱导因子-1α的表达及意义[J].中国现代医学杂志,2005,15(21):3251-3254. 被引量:2
  • 5刘宏斌,杨其昌,陈莉,季晓华,沈屹.乳腺癌中CD105的表达及其预后意义[J].南通大学学报(医学版),2006,26(6):435-437. 被引量:1
  • 6Gabriel CN, Cristina BB, Arlete H, et al. Immunohistochemical evaluation of the microvascular density through the expression of TGF-[ beta](CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas [ J]. Neuropathology, 2008, 28(1):17-23.
  • 7Esin Y, Semih A, Fahrettin G, et al. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma [ J ]. BJU International, 2008, 101 (6) :758 -764.
  • 8Rahmawati M, Daisuke M, Fumio Y, et al. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers [ J ]. Pathology International, 2006, 56 ( 12 ) : 717 -723.
  • 9Staton, CA,Chetwood, ASA,Cameron, IC,et al. The angiogenic switch occurs at the adenoma stage of the adenoma-carcinoma sequence in colorectal cancer [ J ]. Gut,2007, 56(10):1426 -1432.
  • 10Calvin DP, Hammond ME, Pajak TF, et al. Microvessel density > = 60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the radiation therapy oncology group (RTOG) 90 -03 trial [ J ]. Am J Clin Oncol, 2007, 30(4) :406 -419.

共引文献24

同被引文献12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部